BIOMAT Database Logo BIOMAT Database Logo

Polyclonal primitive hematopoietic progenitors can be detected in mobilized peripheral blood from patients with high-risk myelodysplastic syndromes. 1995

M Delforge, and H Demuynck, and P Vandenberghe, and G Verhoef, and P Zachée, and V van Duppen, and P Marijnen, and H Van den Berghe, and M A Boogaerts
Department of Hematology, University Hospital Gasthuisberg, Leuven, Belgium.

Myelodysplastic syndromes (MDS) form a heterogeneous group of clonal hematopoietic disorders with unfavourable prognosis. Allogeneic bone marrow transplantation is the only potentially curative treatment, but remains limited to a small subgroup of younger patients with HLA-compatible donors. As autologous stem cell transplantation is currently being explored as an alternative treatment strategy for MDS, more information needs to be acquired regarding the clonal nature of the progenitor cells in these autografts. Therefore, we have analyzed the clonal patterns of highly purified hematopoietic progenitors and their mature daughter cells in mobilized peripheral blood collections produced from five female patients with high-risk MDS in complete hematologic remission. X-chromosome activation patterns of flow-sorted immature (CD34 + 38low, CD34 + 33low) and committed (CD34 + 38high, CD34 + 33high) progenitors were studied with the polymerase chain reaction-based HUMARA assay. In four patients, a polyclonal remission was shown in all stem cell subpopulations and their mature daughter cells whereas one patient was found to remain skewed in all fractions, except T lymphocytes. This study provides strong evidence that polyclonal immature hematopoietic progenitors can be mobilized and harvested in patients high-risk MDS after treatment with high-dose chemotherapy.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008942 Mitoxantrone An anthracenedione-derived antineoplastic agent. Mitozantrone,CL-232325,DHAQ,Mitoxantrone Acetate,Mitoxantrone Hydrochloride,Mitroxone,NSC-279836,NSC-287836,NSC-299195,NSC-301739,NSC-301739D,Novantron,Novantrone,Onkotrone,Pralifan,Ralenova,Acetate, Mitoxantrone,CL 232325,CL232325,Hydrochloride, Mitoxantrone,NSC 279836,NSC 287836,NSC 299195,NSC 301739,NSC 301739D,NSC279836,NSC287836,NSC299195,NSC301739,NSC301739D
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D002469 Cell Separation Techniques for separating distinct populations of cells. Cell Isolation,Cell Segregation,Isolation, Cell,Cell Isolations,Cell Segregations,Cell Separations,Isolations, Cell,Segregation, Cell,Segregations, Cell,Separation, Cell,Separations, Cell
D002471 Cell Transformation, Neoplastic Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill. Neoplastic Transformation, Cell,Neoplastic Cell Transformation,Transformation, Neoplastic Cell,Tumorigenic Transformation,Cell Neoplastic Transformation,Cell Neoplastic Transformations,Cell Transformations, Neoplastic,Neoplastic Cell Transformations,Neoplastic Transformations, Cell,Transformation, Cell Neoplastic,Transformation, Tumorigenic,Transformations, Cell Neoplastic,Transformations, Neoplastic Cell,Transformations, Tumorigenic,Tumorigenic Transformations
D002999 Clone Cells A group of genetically identical cells all descended from a single common ancestral cell by mitosis in eukaryotes or by binary fission in prokaryotes. Clone cells also include populations of recombinant DNA molecules all carrying the same inserted sequence. (From King & Stansfield, Dictionary of Genetics, 4th ed) Clones,Cell, Clone,Cells, Clone,Clone,Clone Cell
D003114 Colony-Forming Units Assay A cytologic technique for measuring the functional capacity of stem cells by assaying their activity. Clonogenic Cell Assay,Stem Cell Assay,Clonogenic Cell Assays,Colony Forming Units Assays,Colony-Forming Units Assays,Stem Cell Assays,Assay, Clonogenic Cell,Assay, Colony-Forming Units,Assay, Stem Cell,Assays, Clonogenic Cell,Assays, Colony-Forming Units,Assays, Stem Cell,Colony Forming Units Assay
D003561 Cytarabine A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472) Ara-C,Arabinofuranosylcytosine,Arabinosylcytosine,Cytosine Arabinoside,Aracytidine,Aracytine,Cytarabine Hydrochloride,Cytonal,Cytosar,Cytosar-U,beta-Ara C,Ara C,Arabinoside, Cytosine,Cytosar U,beta Ara C

Related Publications

M Delforge, and H Demuynck, and P Vandenberghe, and G Verhoef, and P Zachée, and V van Duppen, and P Marijnen, and H Van den Berghe, and M A Boogaerts
Primitive hematopoietic stem cells shows a polyclonal pattern in myelodysplastic syndromes.
January 2004, Haematologica,
M Delforge, and H Demuynck, and P Vandenberghe, and G Verhoef, and P Zachée, and V van Duppen, and P Marijnen, and H Van den Berghe, and M A Boogaerts
Peripheral blood granulocyte-macrophage progenitors in patients with the myelodysplastic syndromes.
December 1986, Experimental hematology,
M Delforge, and H Demuynck, and P Vandenberghe, and G Verhoef, and P Zachée, and V van Duppen, and P Marijnen, and H Van den Berghe, and M A Boogaerts
Primitive hematopoietic progenitors within mobilized blood are spared by uncontrolled rate freezing.
March 1999, Bone marrow transplantation,
M Delforge, and H Demuynck, and P Vandenberghe, and G Verhoef, and P Zachée, and V van Duppen, and P Marijnen, and H Van den Berghe, and M A Boogaerts
Multi-lineage expansion potential of primitive hematopoietic progenitors: superiority of umbilical cord blood compared to mobilized peripheral blood.
September 2000, Experimental hematology,
M Delforge, and H Demuynck, and P Vandenberghe, and G Verhoef, and P Zachée, and V van Duppen, and P Marijnen, and H Van den Berghe, and M A Boogaerts
Primitive haematopoietic progenitors in the blood of patients with sickle cell disease appear to be endogenously mobilized.
November 2000, British journal of haematology,
M Delforge, and H Demuynck, and P Vandenberghe, and G Verhoef, and P Zachée, and V van Duppen, and P Marijnen, and H Van den Berghe, and M A Boogaerts
Methylation status of the p15INK4B gene in hematopoietic progenitors and peripheral blood cells in myelodysplastic syndromes.
April 2000, Leukemia,
M Delforge, and H Demuynck, and P Vandenberghe, and G Verhoef, and P Zachée, and V van Duppen, and P Marijnen, and H Van den Berghe, and M A Boogaerts
Human hematopoietic stem cells from mobilized peripheral blood can be purified based on CD49f integrin expression.
September 2015, Blood,
M Delforge, and H Demuynck, and P Vandenberghe, and G Verhoef, and P Zachée, and V van Duppen, and P Marijnen, and H Van den Berghe, and M A Boogaerts
In vitro proliferation and expansion of hematopoietic progenitors present in mobilized peripheral blood from normal subjects and cancer patients.
August 2004, Stem cells and development,
M Delforge, and H Demuynck, and P Vandenberghe, and G Verhoef, and P Zachée, and V van Duppen, and P Marijnen, and H Van den Berghe, and M A Boogaerts
Myeloid-derived suppressor cells can be efficiently generated from human hematopoietic progenitors and peripheral blood monocytes.
July 2017, Immunology and cell biology,
M Delforge, and H Demuynck, and P Vandenberghe, and G Verhoef, and P Zachée, and V van Duppen, and P Marijnen, and H Van den Berghe, and M A Boogaerts
Mobilization of hematopoietic progenitors in low-grade myelodysplastic syndromes.
April 2006, Haematologica,
Copied contents to your clipboard!